×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SS02: Preparations for Unexpected Infections from the COVID- 19 Pandemic:Rapid Development and Supply of Vaccines and Drugs for Patients
Session Chair(s)
Akiko Ikeda, RPh
Associate Director, Regulatory Development Dept.
Janssen Pharmaceutical K.K., Japan
Mari Ariyasu
Head of Project Management 4, Senior Director
Shionogi & Co., Ltd., Japan
Speaker(s)
Kazuhiro Tateda, MD, PhD
Toho University, Japan
Professor, Department of Microbiology and Infectious Diseases
Noriko Morikubo
Pfizer R&D Japan G.K., Japan
Regulatory Strategy Group2, Japan Regulatory Portfolio Lead
Satoshi Aida
Teijin Pharma Limited, Japan
Chief Planner, Strategic Planning Department
Have an account?